I don't claim to know what drives Teva's decisions other than that in this case it has no bearing whatsoever on the success or otherwise of these trials. You don't know either, so stop pretending. You really are struggling to connect Teva's decision to the product efficacy. And failing.
Why not give Teva a call and relieve your curiosity. Yankee will give you the number.
MS.. Cured by stem cells ?, page-52
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.11 |
Change
0.010(0.91%) |
Mkt cap ! $1.261B | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.11 | $1.07 | $4.794M | 4.399M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 14500 | $1.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.11 | 141676 | 5 |
View Market Depth
| Last trade - 16.10pm 11/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |